Paper41226561
Application of Antisense Oligonucleotides as an Alternative Approach for Gene Expression Control and Functional Studies.
Szukowska A and 4 others. Int J Mol Sci, 2025. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Application of Antisense Oligonucleotides as an Alternative Approach for Gene Expression Control and Functional Studies. Papers, record 41226561. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41226561
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Application of Antisense Oligonucleotides as an Alternative Approach for Gene Expression Control and Functional Studies.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Oligonucleotides, Antisense | Major topic |
| Gene Expression Regulation | Major topic |
| Humans | |
| Animals |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2021/43/B/NZ9/01730 | National Science Center (NCN) | PubMed |
Source PubMed
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25287293 | Oligonucleotide treatment causes flax β-glucanase up-regulation via changes in gene-body methylation. | BMC Plant Biol | 2014 | https://conductscience.org/library/papers/25287293 | PubMed |
| 2 | 32595687 | Barriers to Efficient Foliar Uptake of dsRNA and Molecular Barriers to dsRNA Activity in Plant Cells. | Front Plant Sci | 2020 | https://conductscience.org/library/papers/32595687 | PubMed |
| 3 | 36923460 | The applicability of the European GMO legislation to epigenetically modified organisms. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/36923460 | PubMed |
| 4 | 38252341 | Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases. | BioDrugs | 2024 | https://conductscience.org/library/papers/38252341 | PubMed |
| 5 | 40634707 | Decomposition of phenotypic heterogeneity in autism reveals underlying genetic programs. | Nat Genet | 2025 | https://conductscience.org/library/papers/40634707 | PubMed |
| 6 | 38748545 | Antisense Oligonucleotide as a New Technology Application for CsLOB1 Gene Silencing Aiming at Citrus Canker Resistance. | Phytopathology | 2024 | https://conductscience.org/library/papers/38748545 | PubMed |
| 7 | 17320507 | Chromatin modifications and their function. | Cell | 2007 | https://conductscience.org/library/papers/17320507 | PubMed |
| 8 | 40377084 | ASOptimizer: optimizing chemical diversity of antisense oligonucleotides through deep learning. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/40377084 | PubMed |
| 9 | 34770939 | RNA Activation-A Novel Approach to Therapeutically Upregulate Gene Transcription. | Molecules | 2021 | https://conductscience.org/library/papers/34770939 | PubMed |
| 10 | 38978517 | Reprogramming of DNA methylation and changes of gene expression in grafted Hevea brasiliensis. | Front Plant Sci | 2024 | https://conductscience.org/library/papers/38978517 | PubMed |
| 11 | 36735698 | Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection. | PLoS One | 2023 | https://conductscience.org/library/papers/36735698 | PubMed |
| 12 | 28839185 | Antisense oligonucleotide and thyroid hormone conjugates for obesity treatment. | Sci Rep | 2017 | https://conductscience.org/library/papers/28839185 | PubMed |
| 13 | 28898654 | Plant cell walls. | Curr Biol | 2017 | https://conductscience.org/library/papers/28898654 | PubMed |
| 14 | 9880552 | Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression. | J Biol Chem | 1999 | https://conductscience.org/library/papers/9880552 | PubMed |
| 15 | 12489851 | Antisense oligonucleotides: basic concepts and mechanisms. | Mol Cancer Ther | 2002 | https://conductscience.org/library/papers/12489851 | PubMed |
| 16 | 39772535 | Metabolic Stability and Targeted Delivery of Oligonucleotides: Advancing RNA Therapeutics Beyond The Liver. | J Med Chem | 2025 | https://conductscience.org/library/papers/39772535 | PubMed |
| 17 | 29784956 | Dynamics and function of DNA methylation in plants. | Nat Rev Mol Cell Biol | 2018 | https://conductscience.org/library/papers/29784956 | PubMed |
| 18 | 30525618 | Synthesis of Protected Amino Hexitol Nucleosides as Building Blocks for Oligonucleotide Synthesis. | J Org Chem | 2018 | https://conductscience.org/library/papers/30525618 | PubMed |
| 19 | 29752304 | Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production. | Neurology | 2018 | https://conductscience.org/library/papers/29752304 | PubMed |
| 20 | 14746510 | Progress in antisense technology. | Annu Rev Med | 2004 | https://conductscience.org/library/papers/14746510 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42936110 | Neuroprotective roles of Klotho signaling in Huntington's disease: From molecular insights to clinical translation. | IBRO Neurosci Rep | 2026 | https://conductscience.org/library/papers/42936110 | PubMed |
| 42851959 | Exploring the Potential of Phosphoramide N‑Benzimidazole Oligonucleotides (PABAOs) as Antisense Agents. | ACS Omega | 2026 | https://conductscience.org/library/papers/42851959 | PubMed |
| 42651807 | Engineering the Future of Precision Medicine: A Comprehensive Guide to RNA Therapeutics. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42651807 | PubMed |
| 42550083 | A targeted mutational strategy aiding in generating antisense RNA to knockdown the Ehrlichia chaffeensis P28-outer membrane protein 19 expression. | J Bacteriol | 2026 | https://conductscience.org/library/papers/42550083 | PubMed |
| 42514590 | Antisense Oligonucleotides as a Gene-Silencing Strategy Regulating Cytosolic G6PDH in Hordeum vulgare. | Plants (Basel) | 2026 | https://conductscience.org/library/papers/42514590 | PubMed |
| 41992206 | Delivery and uptake of free and liposome-encapsulated cholesterol-conjugated antisense oligonucleotides in Atlantic salmon sperm: insights from high-resolution imaging. | BMC Vet Res | 2026 | https://conductscience.org/library/papers/41992206 | PubMed |
| 41869410 | Targeted Delivery of Nucleic Acid Therapeutics: Emerging Carriers and Applications in Common Metabolic and Inflammatory Diseases. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41869410 | PubMed |
| 41754997 | Nucleic-Acid-Based Strategies and Nanotechnology Applications for Targeted Therapy. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41754997 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41226561
GET https://conductscience.org/api/papers/v1/41226561/references?page=2